Agilent
Fresh off its July IPO, the Swiss-American company is expanding its technological and geographical footprints with a series of collaborations and partnerships.
GenomeWeb Index up Slightly in August as Guardant Health Leads on Strength of Q2 Earnings
The GenomeWeb Index outperformed the Dow Jones last month, but underperformed the Nasdaq and the Nasdaq Biotechnology Index.
Agilent Technologies, Partek Partner on End-to-End Bioinformatics Workflow
Partek said that integrating its Partek Flow software with Agilent's clinical and research applications enables use of visualization tools for DNA and RNA applications.
Agilent Technologies Q3 Revenues Rise 26 Percent
Revenues for Agilent's diagnostic and genomics group rose 44 percent to $346 million from $241 million in the year-ago quarter.
Agilent Technologies, Thomas Scientific Ink Distribution Agreement for Genomics Products
Thomas Scientific will make available more than 700 products from Agilent's genomics division, including qPCR instruments, PCR enzymes, and other reagents.
May 25, 2021
Agilent Q2 Revenues Rise 23 Percent
Apr 14, 2021
Mar 9, 2021
Agilent Receives CE Mark for SARS-CoV-2 PCR Test
Mar 4, 2021
Mar 4, 2021
Agilent Prices $850M Senior Notes Offering
Nov 23, 2020
Agilent Q4 Revenues Rise 8 Percent
Aug 18, 2020
Agilent Q3 Revenues Drop 1 Percent
Aug 17, 2020